| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $81K | — | -20.9% |
| Cost of Revenue | $40K | — | +1.8% |
| Gross Profit | $40K | — | -35.3% |
| R&D Expense | $1.1M | — | +1838.6% |
| SG&A Expense | $1.7M | — | +652.1% |
| Operating Income | -$2.8M | — | -99.0% |
| Pre-tax Income | -$3.3M | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $682K | -72.5% | +289.2% |
| Accounts Receivable | $81K | +263.8% | +44.1% |
| Current Assets | $1.2M | -65.1% | -5.8% |
| Total Assets | $1.8M | -55.5% | +46.1% |
| Current Liabilities | $14.9M | +7.5% | +1111.3% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.8M | — | -120.0% |
| Financing Cash Flow | -$37K | — | -108.9% |
| -111.1% |
| Net Income | -$3.3M | — | -111.1% |
| EPS (Basic) | -$0.17 | — | +56.4% |
| EPS (Diluted) | -$0.17 | — | +56.4% |
| $15.0M |
| +7.3% |
| +368.2% |
| Stockholders' Equity | -$13.2M | -33.3% | -572.5% |